Why the study?
Do cardioselective beta-blockers provide benefits that outweigh risks in patients with asthma and concomitant heart failure or history of myocardial infarction?
Population
Patients with asthma and concomitant heart failure or history of myocardial infarction
Design
Review
Authors
Loading...
May inform cautious cardioselective beta-blocker use in asthma with HF or prior MI; leaves open need for randomized trials.
Do cardioselective beta-blockers provide benefits that outweigh risks in patients with asthma and concomitant heart failure or history of myocardial infarction?
This paper discusses the risk-benefit ratio of using cardioselective beta-blockers in patients with both asthma and heart failure or prior myocardial infarction.
Self et al. (2003) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: